0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Obesity Treatment Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-3Q4545
Home | Market Reports | Beauty & Fitness| Weight Loss
Global Obesity Treatment Market Insights and Forecast to 2028
BUY CHAPTERS

Global Obesity Treatment Market Research Report 2025

Code: QYRE-Auto-3Q4545
Report
September 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Obesity Treatment Market Size

The global market for Obesity Treatment was valued at US$ 7129 million in the year 2024 and is projected to reach a revised size of US$ 16990 million by 2031, growing at a CAGR of 13.4% during the forecast period.

Obesity Treatment Market

Obesity Treatment Market

Obesity is a major health problem worldwide responsible for increased morbidity/mortality and high cost for the society. Management of obesity requires multidisciplinary approaches including diet, food supplement, exercise, behavior change, drug, medical device, gut microbiome manipulation, and surgery. Anti-obesity medical devices are an option for subjects who have not responded to more conservative medical treatments but want an alternative to surgery.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Obesity Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Obesity Treatment.
The Obesity Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Obesity Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Obesity Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Obesity Treatment Market Report

Report Metric Details
Report Name Obesity Treatment Market
Accounted market size in year US$ 7129 million
Forecasted market size in 2031 US$ 16990 million
CAGR 13.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Surgical & Implant Devices
  • Medication Therapy
  • Dietary
  • Other
Segment by Application
  • Children
  • Adults
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company NutriSystem, Inc. (U.S.), Kellogg Company (U.S.), Ethicon, Inc. (U.S.), Medtronic (U.S.), F. Hoffmann-La Roche (Switzerland), Atkins Nutritionals, Inc. (U.S.), Herbalife Ltd. (U.S.), Covidien plc (U.S.), Apollo Endosurgery (U.S.), Amer Sports (Finland), Johnson Health Technology, Ltd. (Taiwan), Cybex International (U.S.), USGI Medical (U.S.), Olympus Corporation (Japan), Brunswick Corporation (U.S.), Technogym SpA (Italy)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Obesity Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Obesity Treatment Market growing?

Ans: The Obesity Treatment Market witnessing a CAGR of 13.4% during the forecast period 2025-2031.

What is the Obesity Treatment Market size in 2031?

Ans: The Obesity Treatment Market size in 2031 will be US$ 16990 million.

Who are the main players in the Obesity Treatment Market report?

Ans: The main players in the Obesity Treatment Market are NutriSystem, Inc. (U.S.), Kellogg Company (U.S.), Ethicon, Inc. (U.S.), Medtronic (U.S.), F. Hoffmann-La Roche (Switzerland), Atkins Nutritionals, Inc. (U.S.), Herbalife Ltd. (U.S.), Covidien plc (U.S.), Apollo Endosurgery (U.S.), Amer Sports (Finland), Johnson Health Technology, Ltd. (Taiwan), Cybex International (U.S.), USGI Medical (U.S.), Olympus Corporation (Japan), Brunswick Corporation (U.S.), Technogym SpA (Italy)

What are the Application segmentation covered in the Obesity Treatment Market report?

Ans: The Applications covered in the Obesity Treatment Market report are Children, Adults

What are the Type segmentation covered in the Obesity Treatment Market report?

Ans: The Types covered in the Obesity Treatment Market report are Surgical & Implant Devices, Medication Therapy, Dietary, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Obesity Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Surgical & Implant Devices
1.2.3 Medication Therapy
1.2.4 Dietary
1.2.5 Other
1.3 Market by Application
1.3.1 Global Obesity Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Children
1.3.3 Adults
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Obesity Treatment Market Perspective (2020-2031)
2.2 Global Obesity Treatment Growth Trends by Region
2.2.1 Global Obesity Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Obesity Treatment Historic Market Size by Region (2020-2025)
2.2.3 Obesity Treatment Forecasted Market Size by Region (2026-2031)
2.3 Obesity Treatment Market Dynamics
2.3.1 Obesity Treatment Industry Trends
2.3.2 Obesity Treatment Market Drivers
2.3.3 Obesity Treatment Market Challenges
2.3.4 Obesity Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Obesity Treatment Players by Revenue
3.1.1 Global Top Obesity Treatment Players by Revenue (2020-2025)
3.1.2 Global Obesity Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Obesity Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Obesity Treatment Revenue
3.4 Global Obesity Treatment Market Concentration Ratio
3.4.1 Global Obesity Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Obesity Treatment Revenue in 2024
3.5 Global Key Players of Obesity Treatment Head office and Area Served
3.6 Global Key Players of Obesity Treatment, Product and Application
3.7 Global Key Players of Obesity Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Obesity Treatment Breakdown Data by Type
4.1 Global Obesity Treatment Historic Market Size by Type (2020-2025)
4.2 Global Obesity Treatment Forecasted Market Size by Type (2026-2031)
5 Obesity Treatment Breakdown Data by Application
5.1 Global Obesity Treatment Historic Market Size by Application (2020-2025)
5.2 Global Obesity Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Obesity Treatment Market Size (2020-2031)
6.2 North America Obesity Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Obesity Treatment Market Size by Country (2020-2025)
6.4 North America Obesity Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Obesity Treatment Market Size (2020-2031)
7.2 Europe Obesity Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Obesity Treatment Market Size by Country (2020-2025)
7.4 Europe Obesity Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Obesity Treatment Market Size (2020-2031)
8.2 Asia-Pacific Obesity Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Obesity Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Obesity Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Obesity Treatment Market Size (2020-2031)
9.2 Latin America Obesity Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Obesity Treatment Market Size by Country (2020-2025)
9.4 Latin America Obesity Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Obesity Treatment Market Size (2020-2031)
10.2 Middle East & Africa Obesity Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Obesity Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Obesity Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NutriSystem, Inc. (U.S.)
11.1.1 NutriSystem, Inc. (U.S.) Company Details
11.1.2 NutriSystem, Inc. (U.S.) Business Overview
11.1.3 NutriSystem, Inc. (U.S.) Obesity Treatment Introduction
11.1.4 NutriSystem, Inc. (U.S.) Revenue in Obesity Treatment Business (2020-2025)
11.1.5 NutriSystem, Inc. (U.S.) Recent Development
11.2 Kellogg Company (U.S.)
11.2.1 Kellogg Company (U.S.) Company Details
11.2.2 Kellogg Company (U.S.) Business Overview
11.2.3 Kellogg Company (U.S.) Obesity Treatment Introduction
11.2.4 Kellogg Company (U.S.) Revenue in Obesity Treatment Business (2020-2025)
11.2.5 Kellogg Company (U.S.) Recent Development
11.3 Ethicon, Inc. (U.S.)
11.3.1 Ethicon, Inc. (U.S.) Company Details
11.3.2 Ethicon, Inc. (U.S.) Business Overview
11.3.3 Ethicon, Inc. (U.S.) Obesity Treatment Introduction
11.3.4 Ethicon, Inc. (U.S.) Revenue in Obesity Treatment Business (2020-2025)
11.3.5 Ethicon, Inc. (U.S.) Recent Development
11.4 Medtronic (U.S.)
11.4.1 Medtronic (U.S.) Company Details
11.4.2 Medtronic (U.S.) Business Overview
11.4.3 Medtronic (U.S.) Obesity Treatment Introduction
11.4.4 Medtronic (U.S.) Revenue in Obesity Treatment Business (2020-2025)
11.4.5 Medtronic (U.S.) Recent Development
11.5 F. Hoffmann-La Roche (Switzerland)
11.5.1 F. Hoffmann-La Roche (Switzerland) Company Details
11.5.2 F. Hoffmann-La Roche (Switzerland) Business Overview
11.5.3 F. Hoffmann-La Roche (Switzerland) Obesity Treatment Introduction
11.5.4 F. Hoffmann-La Roche (Switzerland) Revenue in Obesity Treatment Business (2020-2025)
11.5.5 F. Hoffmann-La Roche (Switzerland) Recent Development
11.6 Atkins Nutritionals, Inc. (U.S.)
11.6.1 Atkins Nutritionals, Inc. (U.S.) Company Details
11.6.2 Atkins Nutritionals, Inc. (U.S.) Business Overview
11.6.3 Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Introduction
11.6.4 Atkins Nutritionals, Inc. (U.S.) Revenue in Obesity Treatment Business (2020-2025)
11.6.5 Atkins Nutritionals, Inc. (U.S.) Recent Development
11.7 Herbalife Ltd. (U.S.)
11.7.1 Herbalife Ltd. (U.S.) Company Details
11.7.2 Herbalife Ltd. (U.S.) Business Overview
11.7.3 Herbalife Ltd. (U.S.) Obesity Treatment Introduction
11.7.4 Herbalife Ltd. (U.S.) Revenue in Obesity Treatment Business (2020-2025)
11.7.5 Herbalife Ltd. (U.S.) Recent Development
11.8 Covidien plc (U.S.)
11.8.1 Covidien plc (U.S.) Company Details
11.8.2 Covidien plc (U.S.) Business Overview
11.8.3 Covidien plc (U.S.) Obesity Treatment Introduction
11.8.4 Covidien plc (U.S.) Revenue in Obesity Treatment Business (2020-2025)
11.8.5 Covidien plc (U.S.) Recent Development
11.9 Apollo Endosurgery (U.S.)
11.9.1 Apollo Endosurgery (U.S.) Company Details
11.9.2 Apollo Endosurgery (U.S.) Business Overview
11.9.3 Apollo Endosurgery (U.S.) Obesity Treatment Introduction
11.9.4 Apollo Endosurgery (U.S.) Revenue in Obesity Treatment Business (2020-2025)
11.9.5 Apollo Endosurgery (U.S.) Recent Development
11.10 Amer Sports (Finland)
11.10.1 Amer Sports (Finland) Company Details
11.10.2 Amer Sports (Finland) Business Overview
11.10.3 Amer Sports (Finland) Obesity Treatment Introduction
11.10.4 Amer Sports (Finland) Revenue in Obesity Treatment Business (2020-2025)
11.10.5 Amer Sports (Finland) Recent Development
11.11 Johnson Health Technology, Ltd. (Taiwan)
11.11.1 Johnson Health Technology, Ltd. (Taiwan) Company Details
11.11.2 Johnson Health Technology, Ltd. (Taiwan) Business Overview
11.11.3 Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Introduction
11.11.4 Johnson Health Technology, Ltd. (Taiwan) Revenue in Obesity Treatment Business (2020-2025)
11.11.5 Johnson Health Technology, Ltd. (Taiwan) Recent Development
11.12 Cybex International (U.S.)
11.12.1 Cybex International (U.S.) Company Details
11.12.2 Cybex International (U.S.) Business Overview
11.12.3 Cybex International (U.S.) Obesity Treatment Introduction
11.12.4 Cybex International (U.S.) Revenue in Obesity Treatment Business (2020-2025)
11.12.5 Cybex International (U.S.) Recent Development
11.13 USGI Medical (U.S.)
11.13.1 USGI Medical (U.S.) Company Details
11.13.2 USGI Medical (U.S.) Business Overview
11.13.3 USGI Medical (U.S.) Obesity Treatment Introduction
11.13.4 USGI Medical (U.S.) Revenue in Obesity Treatment Business (2020-2025)
11.13.5 USGI Medical (U.S.) Recent Development
11.14 Olympus Corporation (Japan)
11.14.1 Olympus Corporation (Japan) Company Details
11.14.2 Olympus Corporation (Japan) Business Overview
11.14.3 Olympus Corporation (Japan) Obesity Treatment Introduction
11.14.4 Olympus Corporation (Japan) Revenue in Obesity Treatment Business (2020-2025)
11.14.5 Olympus Corporation (Japan) Recent Development
11.15 Brunswick Corporation (U.S.)
11.15.1 Brunswick Corporation (U.S.) Company Details
11.15.2 Brunswick Corporation (U.S.) Business Overview
11.15.3 Brunswick Corporation (U.S.) Obesity Treatment Introduction
11.15.4 Brunswick Corporation (U.S.) Revenue in Obesity Treatment Business (2020-2025)
11.15.5 Brunswick Corporation (U.S.) Recent Development
11.16 Technogym SpA (Italy)
11.16.1 Technogym SpA (Italy) Company Details
11.16.2 Technogym SpA (Italy) Business Overview
11.16.3 Technogym SpA (Italy) Obesity Treatment Introduction
11.16.4 Technogym SpA (Italy) Revenue in Obesity Treatment Business (2020-2025)
11.16.5 Technogym SpA (Italy) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Obesity Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Surgical & Implant Devices
 Table 3. Key Players of Medication Therapy
 Table 4. Key Players of Dietary
 Table 5. Key Players of Other
 Table 6. Global Obesity Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Obesity Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Obesity Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Obesity Treatment Market Share by Region (2020-2025)
 Table 10. Global Obesity Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Obesity Treatment Market Share by Region (2026-2031)
 Table 12. Obesity Treatment Market Trends
 Table 13. Obesity Treatment Market Drivers
 Table 14. Obesity Treatment Market Challenges
 Table 15. Obesity Treatment Market Restraints
 Table 16. Global Obesity Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Obesity Treatment Market Share by Players (2020-2025)
 Table 18. Global Top Obesity Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Obesity Treatment as of 2024)
 Table 19. Ranking of Global Top Obesity Treatment Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Obesity Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Obesity Treatment, Headquarters and Area Served
 Table 22. Global Key Players of Obesity Treatment, Product and Application
 Table 23. Global Key Players of Obesity Treatment, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Obesity Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Obesity Treatment Revenue Market Share by Type (2020-2025)
 Table 27. Global Obesity Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Obesity Treatment Revenue Market Share by Type (2026-2031)
 Table 29. Global Obesity Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Obesity Treatment Revenue Market Share by Application (2020-2025)
 Table 31. Global Obesity Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Obesity Treatment Revenue Market Share by Application (2026-2031)
 Table 33. North America Obesity Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Obesity Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Obesity Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Obesity Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Obesity Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Obesity Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Obesity Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Obesity Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Obesity Treatment Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Obesity Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Obesity Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Obesity Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Obesity Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Obesity Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Obesity Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 48. NutriSystem, Inc. (U.S.) Company Details
 Table 49. NutriSystem, Inc. (U.S.) Business Overview
 Table 50. NutriSystem, Inc. (U.S.) Obesity Treatment Product
 Table 51. NutriSystem, Inc. (U.S.) Revenue in Obesity Treatment Business (2020-2025) & (US$ Million)
 Table 52. NutriSystem, Inc. (U.S.) Recent Development
 Table 53. Kellogg Company (U.S.) Company Details
 Table 54. Kellogg Company (U.S.) Business Overview
 Table 55. Kellogg Company (U.S.) Obesity Treatment Product
 Table 56. Kellogg Company (U.S.) Revenue in Obesity Treatment Business (2020-2025) & (US$ Million)
 Table 57. Kellogg Company (U.S.) Recent Development
 Table 58. Ethicon, Inc. (U.S.) Company Details
 Table 59. Ethicon, Inc. (U.S.) Business Overview
 Table 60. Ethicon, Inc. (U.S.) Obesity Treatment Product
 Table 61. Ethicon, Inc. (U.S.) Revenue in Obesity Treatment Business (2020-2025) & (US$ Million)
 Table 62. Ethicon, Inc. (U.S.) Recent Development
 Table 63. Medtronic (U.S.) Company Details
 Table 64. Medtronic (U.S.) Business Overview
 Table 65. Medtronic (U.S.) Obesity Treatment Product
 Table 66. Medtronic (U.S.) Revenue in Obesity Treatment Business (2020-2025) & (US$ Million)
 Table 67. Medtronic (U.S.) Recent Development
 Table 68. F. Hoffmann-La Roche (Switzerland) Company Details
 Table 69. F. Hoffmann-La Roche (Switzerland) Business Overview
 Table 70. F. Hoffmann-La Roche (Switzerland) Obesity Treatment Product
 Table 71. F. Hoffmann-La Roche (Switzerland) Revenue in Obesity Treatment Business (2020-2025) & (US$ Million)
 Table 72. F. Hoffmann-La Roche (Switzerland) Recent Development
 Table 73. Atkins Nutritionals, Inc. (U.S.) Company Details
 Table 74. Atkins Nutritionals, Inc. (U.S.) Business Overview
 Table 75. Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Product
 Table 76. Atkins Nutritionals, Inc. (U.S.) Revenue in Obesity Treatment Business (2020-2025) & (US$ Million)
 Table 77. Atkins Nutritionals, Inc. (U.S.) Recent Development
 Table 78. Herbalife Ltd. (U.S.) Company Details
 Table 79. Herbalife Ltd. (U.S.) Business Overview
 Table 80. Herbalife Ltd. (U.S.) Obesity Treatment Product
 Table 81. Herbalife Ltd. (U.S.) Revenue in Obesity Treatment Business (2020-2025) & (US$ Million)
 Table 82. Herbalife Ltd. (U.S.) Recent Development
 Table 83. Covidien plc (U.S.) Company Details
 Table 84. Covidien plc (U.S.) Business Overview
 Table 85. Covidien plc (U.S.) Obesity Treatment Product
 Table 86. Covidien plc (U.S.) Revenue in Obesity Treatment Business (2020-2025) & (US$ Million)
 Table 87. Covidien plc (U.S.) Recent Development
 Table 88. Apollo Endosurgery (U.S.) Company Details
 Table 89. Apollo Endosurgery (U.S.) Business Overview
 Table 90. Apollo Endosurgery (U.S.) Obesity Treatment Product
 Table 91. Apollo Endosurgery (U.S.) Revenue in Obesity Treatment Business (2020-2025) & (US$ Million)
 Table 92. Apollo Endosurgery (U.S.) Recent Development
 Table 93. Amer Sports (Finland) Company Details
 Table 94. Amer Sports (Finland) Business Overview
 Table 95. Amer Sports (Finland) Obesity Treatment Product
 Table 96. Amer Sports (Finland) Revenue in Obesity Treatment Business (2020-2025) & (US$ Million)
 Table 97. Amer Sports (Finland) Recent Development
 Table 98. Johnson Health Technology, Ltd. (Taiwan) Company Details
 Table 99. Johnson Health Technology, Ltd. (Taiwan) Business Overview
 Table 100. Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Product
 Table 101. Johnson Health Technology, Ltd. (Taiwan) Revenue in Obesity Treatment Business (2020-2025) & (US$ Million)
 Table 102. Johnson Health Technology, Ltd. (Taiwan) Recent Development
 Table 103. Cybex International (U.S.) Company Details
 Table 104. Cybex International (U.S.) Business Overview
 Table 105. Cybex International (U.S.) Obesity Treatment Product
 Table 106. Cybex International (U.S.) Revenue in Obesity Treatment Business (2020-2025) & (US$ Million)
 Table 107. Cybex International (U.S.) Recent Development
 Table 108. USGI Medical (U.S.) Company Details
 Table 109. USGI Medical (U.S.) Business Overview
 Table 110. USGI Medical (U.S.) Obesity Treatment Product
 Table 111. USGI Medical (U.S.) Revenue in Obesity Treatment Business (2020-2025) & (US$ Million)
 Table 112. USGI Medical (U.S.) Recent Development
 Table 113. Olympus Corporation (Japan) Company Details
 Table 114. Olympus Corporation (Japan) Business Overview
 Table 115. Olympus Corporation (Japan) Obesity Treatment Product
 Table 116. Olympus Corporation (Japan) Revenue in Obesity Treatment Business (2020-2025) & (US$ Million)
 Table 117. Olympus Corporation (Japan) Recent Development
 Table 118. Brunswick Corporation (U.S.) Company Details
 Table 119. Brunswick Corporation (U.S.) Business Overview
 Table 120. Brunswick Corporation (U.S.) Obesity Treatment Product
 Table 121. Brunswick Corporation (U.S.) Revenue in Obesity Treatment Business (2020-2025) & (US$ Million)
 Table 122. Brunswick Corporation (U.S.) Recent Development
 Table 123. Technogym SpA (Italy) Company Details
 Table 124. Technogym SpA (Italy) Business Overview
 Table 125. Technogym SpA (Italy) Obesity Treatment Product
 Table 126. Technogym SpA (Italy) Revenue in Obesity Treatment Business (2020-2025) & (US$ Million)
 Table 127. Technogym SpA (Italy) Recent Development
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Obesity Treatment Picture
 Figure 2. Global Obesity Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Obesity Treatment Market Share by Type: 2024 VS 2031
 Figure 4. Surgical & Implant Devices Features
 Figure 5. Medication Therapy Features
 Figure 6. Dietary Features
 Figure 7. Other Features
 Figure 8. Global Obesity Treatment Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Obesity Treatment Market Share by Application: 2024 VS 2031
 Figure 10. Children Case Studies
 Figure 11. Adults Case Studies
 Figure 12. Obesity Treatment Report Years Considered
 Figure 13. Global Obesity Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Obesity Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Obesity Treatment Market Share by Region: 2024 VS 2031
 Figure 16. Global Obesity Treatment Market Share by Players in 2024
 Figure 17. Global Top Obesity Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Obesity Treatment as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Obesity Treatment Revenue in 2024
 Figure 19. North America Obesity Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Obesity Treatment Market Share by Country (2020-2031)
 Figure 21. United States Obesity Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Obesity Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Obesity Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Obesity Treatment Market Share by Country (2020-2031)
 Figure 25. Germany Obesity Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Obesity Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Obesity Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Obesity Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Obesity Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Obesity Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Obesity Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Obesity Treatment Market Share by Region (2020-2031)
 Figure 33. China Obesity Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Obesity Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Obesity Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Obesity Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Obesity Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Obesity Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Obesity Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Obesity Treatment Market Share by Country (2020-2031)
 Figure 41. Mexico Obesity Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Obesity Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Obesity Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Obesity Treatment Market Share by Country (2020-2031)
 Figure 45. Turkey Obesity Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Obesity Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Obesity Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. NutriSystem, Inc. (U.S.) Revenue Growth Rate in Obesity Treatment Business (2020-2025)
 Figure 49. Kellogg Company (U.S.) Revenue Growth Rate in Obesity Treatment Business (2020-2025)
 Figure 50. Ethicon, Inc. (U.S.) Revenue Growth Rate in Obesity Treatment Business (2020-2025)
 Figure 51. Medtronic (U.S.) Revenue Growth Rate in Obesity Treatment Business (2020-2025)
 Figure 52. F. Hoffmann-La Roche (Switzerland) Revenue Growth Rate in Obesity Treatment Business (2020-2025)
 Figure 53. Atkins Nutritionals, Inc. (U.S.) Revenue Growth Rate in Obesity Treatment Business (2020-2025)
 Figure 54. Herbalife Ltd. (U.S.) Revenue Growth Rate in Obesity Treatment Business (2020-2025)
 Figure 55. Covidien plc (U.S.) Revenue Growth Rate in Obesity Treatment Business (2020-2025)
 Figure 56. Apollo Endosurgery (U.S.) Revenue Growth Rate in Obesity Treatment Business (2020-2025)
 Figure 57. Amer Sports (Finland) Revenue Growth Rate in Obesity Treatment Business (2020-2025)
 Figure 58. Johnson Health Technology, Ltd. (Taiwan) Revenue Growth Rate in Obesity Treatment Business (2020-2025)
 Figure 59. Cybex International (U.S.) Revenue Growth Rate in Obesity Treatment Business (2020-2025)
 Figure 60. USGI Medical (U.S.) Revenue Growth Rate in Obesity Treatment Business (2020-2025)
 Figure 61. Olympus Corporation (Japan) Revenue Growth Rate in Obesity Treatment Business (2020-2025)
 Figure 62. Brunswick Corporation (U.S.) Revenue Growth Rate in Obesity Treatment Business (2020-2025)
 Figure 63. Technogym SpA (Italy) Revenue Growth Rate in Obesity Treatment Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS